These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 408022)

  • 1. Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.
    Tiesjema RH; Beuvery EC; te Pas BJ
    Bull World Health Organ; 1977; 55(1):43-8. PubMed ID: 408022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.
    Artenstein MS
    Bull World Health Organ; 1971; 45(3):287-90. PubMed ID: 5316909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Observations on the reactions and preventive efficacy of lyophilized group A meningococcal polysaccharide vaccine (author's transl)].
    Song BH; Liu DG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Jan; 16(1):39-41. PubMed ID: 6807642
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal polysaccharide vaccines.
    Gold R
    Hosp Pharm; 1977 Apr; 12(4):201. PubMed ID: 10305440
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides.
    Peltola H; Safary A; Käyhty H; Karanko V; André FE
    Pediatrics; 1985 Jul; 76(1):91-6. PubMed ID: 3925430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of polysaccharide vaccines for the prevention of meningococcal diseases.
    Gotschlich EC
    Monogr Allergy; 1975; 9():245-58. PubMed ID: 804088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
    Zhao JW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 14. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
    Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
    NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal polysaccharide vaccines: recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1977 Sep; 16(9):764-5. PubMed ID: 408072
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and control of Neisseria meningitidis vaccines.
    Frasch CE
    Adv Biotechnol Processes; 1990; 13():123-45. PubMed ID: 2110462
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of meningococcal disease by group C polysaccharide vaccine.
    Artenstein MS; Gold R; Zimmerly JG; Wyle FA; Schneider H; Harkins C
    N Engl J Med; 1970 Feb; 282(8):417-20. PubMed ID: 4983754
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide.
    Artenstein MS; Brandt BL
    J Immunol; 1975 Jul; 115(1):5-7. PubMed ID: 807629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.